Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioBeet is a biotechnology company focused on the development and commercialization of high-potency beetroot-derived compounds for cardiovascular health and metabolic wellness. The company utilizes a proprietary extraction and stabilization process to maximize the bioavailability of dietary nitrates and betalains, which serve as precursors to nitric oxide. Their primary product offerings target the management of blood pressure and the enhancement of physical endurance through improved oxygen utilization. BioBeet operates at the intersection of clinical nutrition and pharmaceutical-grade supplements, providing evidence-based solutions for both clinical populations and the high-performance sports market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioBeet.